Mast cells as therapeutic target in cancer

被引：61

作者：

Ribatti, Domenico ^{[1
,2
]}

机构：

[1] Univ Bari, Sch Med, Dept Basic Med Sci Neurosci & Sensory Organs, Policlin Piazza G Cesare 11, I-70124 Bari, Italy

[2] Natl Canc Inst Giovanni Paolo II, Bari, Italy

来源：

EUROPEAN JOURNAL OF PHARMACOLOGY | 2016年 / 778卷

关键词：

Anticancer agents; Mast cells; Tryptase; Tumor growth; Tyrosine kinase inhibitors; TYROSINE KINASE INHIBITOR; BONE-MARROW ANGIOGENESIS; CHRONIC LYMPHOCYTIC-LEUKEMIA; ENDOTHELIAL GROWTH-FACTOR; HUMAN-BREAST-CANCER; CHORIOALLANTOIC MEMBRANE; SYSTEMIC MASTOCYTOSIS; TUMOR ANGIOGENESIS; TRYPTASE ACTIVITY; PULMONARY ADENOCARCINOMA;

D O I：

10.1016/j.ejphar.2015.02.056

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Mast cells promote tumorigenesis and tumor progression, and have functions that favor the host. Increased mast cell number correlates with a poor prognosis in several human tumors. In different vascular tumors, as well as a number of hematological and solid tumors, mast cell accumulation correlate with increased neovascularization, tumor aggressiveness, and metastatic spread. Mast cells might act as a new target for the adjuvant treatment of tumors through the selective inhibition of angiogenesis, tissue remodeling and tumor -promoting molecules, permitting the secretion of cytotoxic cytokines and preventing mast cell -mediated immune suppression. (C) 2015 Elsevier B.V. All rights reserved.

引用

页码：152 / 157

页数：6

共 50 条

[21] Mast cells and angiogenesis in haematological malignancies [J].

Ribatti, Domenico ;

Crivellato, Enrico ;

Molica, Stefano .

LEUKEMIA RESEARCH, 2009, 33 (07) :876-879

[22] Emerging Role of Apelin as a Therapeutic Target in Cancer: A Patent Review [J].

Rayalam, Srujana ;

Della-Fera, Mary A. ;

Kasser, Thomas ;

Warren, William ;

Baile, Clifton A. .

RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (03) :367-372

[23] Mast Cells and Resistance to Immunotherapy in Cancer [J].

Ribatti, Domenico .

ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2023, 71 (01)

[24] The complexity of the complicity of mast cells in cancer [J].

Nechushtan, Hovav .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2010, 42 (05) :551-554

[25] Mast Cells and Resistance to Immunotherapy in Cancer [J].

Domenico Ribatti .

Archivum Immunologiae et Therapiae Experimentalis, 2023, 71

[26] MAST CELLS AND CANCER: ENEMIES OR ALLIES? [J].

Dyduch, Grzegorz ;

Kaczmarczyk, Karolina ;

Okon, Krzysztof .

POLISH JOURNAL OF PATHOLOGY, 2012, 63 (01) :1-7

[27] Angiogenesis as a therapeutic target in breast cancer [J].

Koutras, Angelos K. ;

Starakis, Ioannis ;

Lymperatou, Dionysia ;

Kalofonos, Haralabos P. .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (12) :1230-1238

[28] The angiogenic process as a therapeutic target in cancer [J].

Bridges, Esther M. ;

Harris, Adrian L. .

BIOCHEMICAL PHARMACOLOGY, 2011, 81 (10) :1183-1191

[29] CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's macroglobulinemia and mast cell disorders [J].

Santos, Daniel Ditzel ;

Hatjiharissi, Evdoxia ;

Tournilhac, Olivier ;

Chemaly, Mariana Z. A. ;

Leleu, Xavier ;

Xu, Lian ;

Patterson, Christopher ;

Branagan, Andrew R. ;

Manning, Robert J. ;

Ho, Allen W. ;

Hunter, Zachary R. ;

Dimmock, Elizabeth A. ;

Kutok, Jeffery L. ;

Churchill, Winthrop H. ;

Castells, Mariana C. ;

Tai, Yu-Tzu ;

Anderson, Kenneth C. ;

Treon, Steven P. .

CLINICAL LYMPHOMA & MYELOMA, 2006, 6 (06) :478-483

[30] Human Mast Cells From Adipose Tissue Target and Induce Apoptosis of Breast Cancer Cells [J].

Plotkin, Jesse D. ;

Elias, Michael G. ;

Fereydouni, Mohammad ;

Daniels-Wells, Tracy R. ;

Dellinger, Anthony L. ;

Penichet, Manuel L. ;

Kepley, Christopher L. .

FRONTIERS IN IMMUNOLOGY, 2019, 10

← 1 2 3 4 5 →